0001567619-22-016358.txt : 20220816 0001567619-22-016358.hdr.sgml : 20220816 20220816120218 ACCESSION NUMBER: 0001567619-22-016358 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220816 DATE AS OF CHANGE: 20220816 EFFECTIVENESS DATE: 20220816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medcura, Inc. CENTRAL INDEX KEY: 0001672180 IRS NUMBER: 260649449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456056 FILM NUMBER: 221169127 BUSINESS ADDRESS: STREET 1: 387 TECHNOLOGY DR. CITY: COLLEGE PARK STATE: MD ZIP: 20742 BUSINESS PHONE: 3014053585 MAIL ADDRESS: STREET 1: 387 TECHNOLOGY DR. CITY: COLLEGE PARK STATE: MD ZIP: 20742 FORMER COMPANY: FORMER CONFORMED NAME: gel-e, Inc. DATE OF NAME CHANGE: 20160919 FORMER COMPANY: FORMER CONFORMED NAME: Remedium Technologies, INC. DATE OF NAME CHANGE: 20160413 D 1 primary_doc.xml X0708 D LIVE 0001672180 Medcura, Inc. 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 (240) 684-8801 DELAWARE Remedium Technologies, Inc. gel-e, Inc. Remedium Technologies, INC. Corporation true Matthew Dowling 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Executive Officer Director Mr. Dowling is the Chief Scientific Officer. Larry Tiffany 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Director Jim Buck 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Buck is the Chief Executive Officer of the Issuer. Rich Vincent 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Executive Officer Mr. Vincent is the Chief Financial Officer of the Issuer. Biotechnology Decline to Disclose 06b false 2022-07-29 false true true true true true Convertible Promissory Notes; Common Stock or Series A-1 Preferred Stock underlying the convertible promissory notes. false 0 5600000 3207050 2392950 The total offering amount includes the interest of 6% on the promissory notes, which interest is convertible into equity securities of the Issuer. false 26 0 0 0 false Medcura, Inc. /s/ Jim Buck Jim Buck Chief Executive Officer of the Issuer 2022-08-15